Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Despite reports suggesting that tissue-resident natural killer (trNK) cells cause ischemic kidney injury, their contribution to the development of tubulointerstitial fibrosis has not been determined. This study hypothesized that the depletion of trNK cells may ameliorate renal fibrosis by affecting transglutaminase 2/syndecan-4 interactions. Aristolochic acid nephropathy (AAN) was induced in C57BL/6 mice as an experimental model of kidney fibrosis. The mice were treated with anti-asialo GM1 (ASGM1) or anti-NK1.1 antibodies to deplete NK cells. Although both ASGM1 and NK1.1 antibodies suppressed renal NKp46＋DX5＋ NK cells, renal NKp46＋DX5- cells were resistant to suppression by ASGM1 or NK1.1 antibodies during the development of tubulointerstitial fibrosis in the AAN-induced mouse model. Western blot analysis showed that both antibodies increased the expression of fibronectin, transglutaminase 2, and syndecan-4. These findings indicate that trNK cells played an exacerbating role in tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in the AAN-induced mouse model.
Abstract
Despite reports suggesting that tissue-resident natural killer (trNK) cells cause ischemic kidney injury, their contribution to the development of tubulointerstitial fibrosis has not been determined. This study hypothesized that the depletion of trNK cells may ameliorate renal fibrosis by affecting transglutaminase 2/syndecan-4 interactions. Aristolochic acid nephropathy (AAN) was induced in C57BL/6 mice as an experimental model of kidney fibrosis. The mice were treated with anti-asialo GM1 (ASGM1) or anti-NK1.1 antibodies to deplete NK cells. Although both ASGM1 and NK1.1 antibodies suppressed renal NKp46＋DX5＋ NK cells, renal NKp46＋DX5- cells were resistant to suppression by ASGM1 or NK1.1 antibodies during the development of tubulointerstitial fibrosis in the AAN-induced mouse model. Western blot analysis showed that both antibodies increased the expression of fibronectin, transglutaminase 2, and syndecan-4. These findings indicate that trNK cells played an exacerbating role in tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in the AAN-induced mouse model.
참고문헌 (22)
- Meguid El Nahas A, "Chronic kidney disease : the global challenge", Lancet, 365, pp.331~340 (2005)
- Huang L, "Development of a chronic kidney disease model in C57BL", 6 mice with relevance to human pathology, 2013, pp.3, 12~29
- Lorand L, "Transglutaminases : crosslinking enzymes with pleiotropic functions", Nat Rev Mol Cell Biol, 4, pp.140~156 (2003)
- Oh K, "Epithelial transglutaminase 2 is needed for T cell interleukin-17production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice", J Exp Med, 208, pp.1707~1719 (2011)
- Scarpellini A, "Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2", J Biol Chem, 284, pp.18411~18423 (2009)
- Scarpellini A, "Syndecan-4knockout leads to reduced extracellular transglutaminase-2and protects against tubulointerstitial fibrosis", J Am Soc Nephrol, 25, pp.1013~1027 (2014)
- Hasmim M, "Critical Role of Tumor Microenvironment in Shaping NK Cell Functions : Implication of Hypoxic Stress", Front Immunol, 6, pp.482~ (2015)
- Peng H, "Liver-resident NK cells confer adaptive immunity in skin-contact inflammation", J Clin Invest, 123, pp.1444~1456 (2013)
- Sojka DK, "Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells", Elife, 3, pp.e01659~ (2014)
- Victorino F, "Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody", J Immunol, 195, pp.4973~4985 (2015)
- Law BMP, "Interferon-gamma production by tubulointerstitial human CD56(bright)natural killer cells contributes to renal fibrosis and chronic kidney disease progression", Kidney Int, 92, pp.79~88 (2017)
- Kim SY, "IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells", J Interferon Cytokine Res, 22, pp.677~682 (2002)
- Shi FD, "Organ-specific features of natural killer cells", Nat Rev Immunol, 11, pp.658~671 (2011)
- Shi FD, "Reciprocal regulation between natural killer cells and autoreactive T cells", Nat Rev Immunol, 6, pp.751~760 (2006)
- French AR, "Natural killer cells and autoimmunity", Arthritis Res Ther, 6, pp.8~14 (2004)
- Flodstrom-Tullberg M, "Natural killer cells in human autoimmunity", Curr Opin Immunol, 21, pp.634~640 (2009)
- Ehl S, "A comparison of efficacy and specificity of three NK depleting antibodies", J Immunol Methods, 199, pp.149~153 (1996)
- Jiang D, "Regulation of pulmonary fibrosis by chemokine receptor CXCR3", J Clin Invest, 114, pp.291~299 (2004)
- Vosshenrich CA, "Distinguishing features of developing natural killer cells", Curr Opin Immunol, 17, pp.151~158 (2005)
- Shin S, "Interpreting CD56+and CD163+ infiltrates in early versus late renal transplant biopsies", Am J Nephrol, 41, pp.362~369 (2015)
- Bloushtain N, "Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30and NKp46", J Immunol, 173, pp.2392~2401 (2004)
- Wee YM, "Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation", Cell Transplant, 17, pp.1257~1269 (2008)